Shilanski & Associates, Inc. Albemarle Corp Transaction History

Shilanski & Associates, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 02, 2022	SELL	$187.76 - $270.92 $1.28 Million - $1.85 Million	-6,815 Closed	0 $0
Q1 2022 Apr 20, 2022	BUY	$172.09 - $246.0 $2,581 - $3,690	15 Added 0.22%	6,815 $1.51 Million
Q4 2021 Jan 12, 2022	SELL	$214.16 - $283.8 $11,992 - $15,892	-56 Reduced 0.82%	6,800 $1.59 Million
Q3 2021 Oct 12, 2021	BUY	$167.91 - $244.03 $38,115 - $55,394	227 Added 3.42%	6,856 $1.5 Million
Q2 2021 Aug 13, 2021	BUY	$143.7 - $176.01 $63,659 - $77,972	443 Added 7.16%	6,629 $1.12 Million
Q1 2021 Apr 14, 2021	BUY	$140.69 - $185.25 $6,893 - $9,077	49 Added 0.8%	6,186 $905,000
Q4 2020 Feb 03, 2021	BUY	$86.73 - $149.91 $532,262 - $919,997	6,137 New	6,137 $905,000

909

104M

8.35M

14.3M

Ticker ALB
Exchange NYSE
Sector Basic Materials
Industry Specialty Chemicals
Shares Outstandng 117,129,000
Market Cap $9.86B
Description
Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Lithium, Bromine, and Catalysts. The Lithium segment offers lithium compounds, including lithium carbonate, lithium hydroxide, lithium chloride, and lithium specialties; and reagents, such as butyllithium and li...

Get notified when there are updates to the investment portfolio of Shilanski & Associates, Inc., based on Form 13F filings with the SEC.

Stay updated on Shilanski & Associates, Inc. with notifications on news.